Swiss National Bank Grows Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Swiss National Bank boosted its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 2.1% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 200,468 shares of the company’s stock after purchasing an additional 4,100 shares during the period. Swiss National Bank’s holdings in Acadia Healthcare were worth $15,965,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. raised its holdings in Acadia Healthcare by 1.5% during the third quarter. Vanguard Group Inc. now owns 8,758,004 shares of the company’s stock valued at $684,700,000 after acquiring an additional 131,959 shares during the period. Wellington Management Group LLP raised its holdings in Acadia Healthcare by 17.8% during the first quarter. Wellington Management Group LLP now owns 5,626,846 shares of the company’s stock valued at $406,540,000 after acquiring an additional 850,056 shares during the period. FMR LLC raised its holdings in Acadia Healthcare by 117.7% during the first quarter. FMR LLC now owns 5,279,609 shares of the company’s stock valued at $381,452,000 after acquiring an additional 2,854,393 shares during the period. State Street Corp increased its holdings in shares of Acadia Healthcare by 1.5% in the first quarter. State Street Corp now owns 2,541,619 shares of the company’s stock worth $183,632,000 after purchasing an additional 38,321 shares during the last quarter. Finally, Durable Capital Partners LP increased its holdings in shares of Acadia Healthcare by 30.8% in the fourth quarter. Durable Capital Partners LP now owns 1,941,595 shares of the company’s stock worth $159,832,000 after purchasing an additional 457,687 shares during the last quarter.

Acadia Healthcare Trading Down 0.1 %

Shares of NASDAQ ACHC opened at $72.62 on Tuesday. Acadia Healthcare Company, Inc. has a 1-year low of $66.49 and a 1-year high of $89.85. The business’s 50 day moving average is $72.41 and its two-hundred day moving average is $73.57. The stock has a market capitalization of $6.70 billion, a P/E ratio of -345.81, a PEG ratio of 1.97 and a beta of 1.44. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.81 and a quick ratio of 0.81.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on ACHC shares. TheStreet cut Acadia Healthcare from a “b” rating to a “c” rating in a report on Friday, November 3rd. Royal Bank of Canada reduced their target price on Acadia Healthcare from $99.00 to $94.00 and set an “outperform” rating on the stock in a report on Tuesday, November 7th. Cantor Fitzgerald lifted their target price on Acadia Healthcare from $83.00 to $85.00 and gave the stock a “neutral” rating in a report on Thursday, September 14th. Finally, StockNews.com started coverage on Acadia Healthcare in a report on Thursday, October 5th. They issued a “hold” rating on the stock. One research analyst has rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $85.71.

Insider Buying and Selling at Acadia Healthcare

In other Acadia Healthcare news, EVP John S. Hollinsworth sold 20,000 shares of the business’s stock in a transaction that occurred on Friday, November 10th. The stock was sold at an average price of $73.00, for a total transaction of $1,460,000.00. Following the completion of the transaction, the executive vice president now owns 177,130 shares in the company, valued at $12,930,490. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other Acadia Healthcare news, Director Debra K. Osteen sold 15,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 8th. The stock was sold at an average price of $74.21, for a total transaction of $1,113,150.00. Following the completion of the transaction, the director now owns 718,833 shares in the company, valued at $53,344,596.93. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP John S. Hollinsworth sold 20,000 shares of the business’s stock in a transaction that occurred on Friday, November 10th. The shares were sold at an average price of $73.00, for a total value of $1,460,000.00. Following the transaction, the executive vice president now owns 177,130 shares of the company’s stock, valued at approximately $12,930,490. The disclosure for this sale can be found here. Insiders sold 140,000 shares of company stock worth $10,350,325 over the last 90 days. Company insiders own 2.80% of the company’s stock.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. It offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers, eating disorder facilities, and outpatient clinics.